Impact BioMedical (IBO) closed its initial public offering of 1.5 million common shares at $3 apiece.
Underwriters have a 45-day option to acquire up to 225,000 additional shares, the company said Tuesday in a statement.
Impact BioMedical shares fell 13% in recent Tuesday trading.
Price: 2.33, Change: -0.35, Percent Change: -13.10
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。